http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012311483-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f21c1009c60308a64b8e7dc0bb989632
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3933c8f2baa5fa8bfa866477d251365
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
filingDate 2012-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0932ee882ee51a69bdac8da1d6aaa573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14fe7827f7a2269d0336a7cf483910a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38fa3c2e7f476064fa59501a8d25938d
publicationDate 2016-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2012311483-B2
titleOfInvention Combination therapy using immunoglobulin and C1-inhibitor
abstract Methods are disclosed for treating cerebral ischemia using a combination of C1-INH and immunoglobulin, such as human plasma derived immunoglobulin (IVIG).
priorityDate 2011-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007073186-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004075837-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010143325-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID17175
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID64459
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID64023
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25692
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281407
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507060
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100970830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71068
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID505819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88246392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5648
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4929
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID10747
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454298346
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID17174
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100128998
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86242
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519733
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419567924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505428
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID522347

Total number of triples: 58.